Cargando…
Fibroblast growth factor 21 reflects liver fat accumulation and dysregulation of signalling pathways in the liver of C57BL/6J mice
Fibroblast growth factor 21 (Fgf21) has emerged as a potential plasma marker to diagnose non-alcoholic fatty liver disease (NAFLD). To study the molecular processes underlying the association of plasma Fgf21 with NAFLD, we explored the liver transcriptome data of a mild NAFLD model of aging C57BL/6J...
Autores principales: | Rusli, Fenni, Deelen, Joris, Andriyani, Evi, Boekschoten, Mark V., Lute, Carolien, van den Akker, Erik B., Müller, Michael, Beekman, Marian, Steegenga, Wilma T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965761/ https://www.ncbi.nlm.nih.gov/pubmed/27470139 http://dx.doi.org/10.1038/srep30484 |
Ejemplares similares
-
A weekly alternating diet between caloric restriction and medium fat protects the liver from fatty liver development in middle-aged C57BL/6J mice
por: Rusli, Fenni, et al.
Publicado: (2015) -
Intermittent calorie restriction largely counteracts the adverse health effects of a moderate‐fat diet in aging C57BL/6J mice
por: Rusli, Fenni, et al.
Publicado: (2017) -
Plasticity of lifelong calorie‐restricted C57BL/6J mice in adapting to a medium‐fat diet intervention at old age
por: Rusli, Fenni, et al.
Publicado: (2017) -
Integrative analysis of gut microbiota composition, host colonic gene expression and intraluminal metabolites in aging C57BL/6J mice
por: van der Lugt, Benthe, et al.
Publicado: (2018) -
Structural, functional and molecular analysis of the effects of aging in the small intestine and colon of C57BL/6J mice
por: Steegenga, Wilma T, et al.
Publicado: (2012)